2016-07-15 15:39

 

Pharmaceutical deputy director of the Ministry of chemical industry Jiao Wei led a delegation to visit the U.S. Xinkaihe

 

[straight news network reported, Beijing, July 15 (Kangmei pharmaceutical) July 10, the Ministry of Commerce Investment Promotion Bureau of medicine and chemical industry, deputy director of the Department of an in Ji'an City Vice Mayor Wang Jingnan and other leaders, accompanied by, the rate of international project delegation to Kang beauty Xinkaihe exchange visits. Kang beauty Xinkaihe standing deputy general manager of the company Li Xuejun warm reception.
The delegation visited the Xinkai Kang beauty products, a detailed understanding of the traditional Chinese medicine pharmaceutical industry chain development strategy and "Internet plus big health industry layout of the country, praised the development strategy and development model of the U.S. pharmaceutical, said that the U.S. pharmaceutical in promoting the development of our country, ginseng industry leading the development of China's health industry contributions.
The delegation said that as the leading enterprises of China's traditional Chinese medicine industry, Kangmei pharmaceutical station upgrade development at the height of the industry, innovation and development of ideas, innovative services, innovation management, lead the development of our country "Internet plus big health industry norms, boosting the ginseng industry in China modernization and standardization International development. I hope the U.S. pharmaceutical and give full play to their own advantages in the health industry, especially in the Chinese medicine industry chain resource platform and the "Internet plus big health industry first mover advantage, outstanding R & D capability construction, build brand standards and business model innovation for Chinese medicine industry, especially the standard of ginseng industry modernization, standardization and internationalization to make new and greater contributions.
It is understood. The effects of group members by the Jilin Province Economic and Technological Cooperation Bureau project director Wu Junmin, deputy director Zhang Linlin, Canada Long Park capital, Zhang Hui, Hisun Pharmaceutical Group Chief formulation of international business on behalf of Wang Fei, project investment, deputy general Deng Jiufa, and treasure medicine industry in the United States AceBios China B2B sales Yong, general manager, business development vice president he Junru, Sihuan Pharmaceutical International Group commercial director Zhang Limin composition. 3
Editor: Xiao Shen
Interpretation of the news hot spots, showing sensitive events, more exclusive analysis, in the "things" WeChat, scan two-dimensional code free reading.